REGN•benzinga•
Wells Fargo Maintains Overweight on Regeneron Pharmaceuticals, Raises Price Target to $800
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 12, 2022 by benzinga